Sector: Specialty Chemicals
Latest Quote @ Wed Jun 6 21:44:17 (15 min delayed)
Last Day's Data
Verenium Corporation engages in the development and commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as high-performance specialty enzymes for applications within the biofuels, industrial, and health and nutrition markets. It produces fuel-grade ethanol from an array of feedstocks, including sugarcane bagasse, energy crops, agricultural waste, and wood products. The company operates an integrated cellulosic ethanol pilot facility in Jennings, Louisiana. Verenium also possesses an array of enzymes derived from bio-diverse environments, as well as patented DirectEvolution technologies. The company's biofuels products include Fuelzyme-LF and Purifine (biodiesel); industrial processes products comprise Luminase PB-100 and Luminase PB-200, Purifine (edible oil), and Pyrolase enzymes; and health and nutrition products consist of proteins/enzymes, such as Phyzyme phytase, Quantum phytase, and Bayovac SRS. In addition, it is developing a collection of enzymes capable of converting corn biomass to cellulosic ethanol and other chemicals. Verenium has alliances with Marubeni Corporation and Tsukishima Kikai Corporation, LTD.; Sid Martin Biotechnology Development Incubator University of Florida; The University of Florida; DuPont Bio-Based Materials; New Zealand Crown Research Institutes, Scion and AgResearch; Syngenta AG; BASF; Bunge Oils; Cargill Health and Food Technologies; DSM Pharma Chemicals; Danisco; Bayer Animal Health; Merck & Co., Inc.; Medarex; Xoma; and Fermic. The company was founded in 1992 and is headquartered in Cambridge, Massachusetts.